Old Web
English
Sign In
Acemap
>
authorDetail
>
Taylor M. Weis
Taylor M. Weis
University of Michigan
Medicine
Internal medicine
Oncology
Immunology
Immune checkpoint
5
Papers
36
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical Considerations for the Use of FLT3 Inhibitors in Acute Myeloid Leukemia
2019
Critical Reviews in Oncology Hematology
Taylor M. Weis
Bernard L. Marini
Dale L. Bixby
Anthony J. Perissinotti
Show All
Source
Cite
Save
Citations (25)
Immune related adverse events in NSCLC patients treated with immune checkpoint therapy who received the influenza vaccination versus no vaccination.
2019
Journal of Clinical Oncology
Haritha G. Reddy
Taylor M. Weis
Shannon Hough
Stephanie Daignault
Bryan J. Schneider
Show All
Source
Cite
Save
Citations (0)
Utilizaton of patient reported outcomes measures (PROM) to characterize symptom burden and adherence associated with oral oncolytic therapy.
2019
Journal of Clinical Oncology
Emily Mackler
Taylor M. Weis
Kelly Marie Procailo
Vincent D. Marshall
Karen B. Farris
Show All
Source
Cite
Save
Citations (0)
Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy:
2019
Journal of Oncology Pharmacy Practice
Taylor M. Weis
Shannon Hough
Haritha G. Reddy
Stephanie Daignault-Newton
Gregory P. Kalemkerian
Show All
Source
Cite
Save
Citations (9)
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas.
2019
Leukemia & Lymphoma
Taylor M. Weis
Bernard L. Marini
Victoria R. Nachar
Anna Brown
Tycel J. Phillips
Julia Brown
Ryan A. Wilcox
Mark S. Kaminski
Sumana Devata
Anthony J. Perissinotti
Show All
Source
Cite
Save
Citations (2)
1